Synaptic Congenital Myasthenic Syndrome in Three Patients due to a Novel Missense Mutation (T441A) of the COLQ Gene

Abstract

Congenital myasthenic syndromes (CMS) with deficiency of endplate acetylcholinesterase (AChE) are caused by mutations in the synapse specific collagenic tail subunit gene (COLQ) of AChE. We identified a novel missense mutation (T441A) homozygously in three CMS patients from two unrelated German families. The mutation is located in the C-terminal region of the ColQ protein, which initiates assembly of the triple helix, and is essential for insertion of the tail subunit into the basal lamina. Density gradient analysis of AChE extracted from muscle of one of the patients revealed the absence of asymmetric AChE. All patients were characterized by an onset of disease in childhood, exercise-induced proximal weakness, absence of ptosis and ophthalmoparesis, a decremental EMG response, and deterioration in response to anticholinesterase drugs. However, age at onset, disease progression, disease severity, and functional impairment varied considerably among the three patients. As adults, two siblings from one family experience only mild impairment, while the third patient requires a wheelchair for most of the day and assisted ventilation at night.

Key words

Congenital myastenic syndrome (CMS) - collagenic tail of endplate acetylcholinesterase (ColQ) - acetylcholinesterase (AChE) - endplate acetylcholinesterase deficiency (EAD) - COLQ mutation

References

• 1 Abicht A, Stucka R, Karcagi V, Herczegfalvi A, Horvath R, Mortier W. et al . A common mutation (ε1267delG) in congenital myasthenic patients of Gypsy ethnic origin.  Neurology. 1999;  53 1564-1569
• 2 Beeson D, Newland C, Croxen R, Buckel A, Li F Y, Larsson C. et al . Congenital myasthenic syndromes. Studies of the AChR and other candidate genes.  Ann N Y Acad Sci. 1998;  841 181-183
• 3 Bon S, Ayon A, Leroy J, Massoulie J. Trimerization domain of the collagen tail of acetylcholinesterase.  Neurochem Res. 2003;  28 523-535
• 4 Donger C, Krejci E, Serradell A P, Eymard B, Bon S, Nicole S. et al . Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic).  Am J Hum Genet. 1998;  63 967-975
• 5 Ellman G L, Courtney K D, Andres Jr V, Feather-Stone R M. A new and rapid colorimetric determination of acetylcholinesterase activity.  Biochem Pharmacol. 1961;  7 88-95
• 6 Engel A G. Myasthenic syndromes. Engel AG Myology. 2nd ed. New York; McGraw-Hill 1994: 1798-1835
• 7 Engel A G, Ohno K, Sine S. Congenital myasthenic syndromes.  Arch Neurol. 1999;  56 163-167
• 8 Engel A G. 73rd ENMC International Workshop: congenital myasthenic syndromes. 22 - 23 October, 1999, Naarden, The Netherlands.  Neuromuscul Disord. 2001;  11 315-321
• 9 Engel A G, Ohno K, Sine S M. Congenital myasthenic syndromes: progress over the past decade.  Muscle Nerve. 2003;  27 4-25
• 10 Ishigaki K, Nicolle D, Krejci E, Leroy J P, Koenig J, Fardeau M. et al . Two novel mutations in the COLQ gene cause endplate acetylcholinesterase deficiency.  Neuromuscul Disord. 2003;  13 236-244
• 11 Kimbell L M, Ohno K, Engel A G, Rotundo R L. C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse.  J Biol Chem. 2004;  279 10997-11005
• 12 Krejci E, Thomine S, Boschetti N, Legay C, Sketelj J, Massoulie J. The mammalian gene of acetylcholinesterase-associated collagen.  J Biol Chem. 1997;  272 22840-22847
• 13 Ohno K, Brengman J, Tsujino A, Engel A G. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme.  Proc Natl Acad Sci USA. 1998;  95 9654-9659
• 14 Ohno K, Brengman J M, Felice K J, Cornblath D R, Engel A G. Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A→G splice-donor-site mutation at position + 3 of the collagen-like-tail-subunit gene (COLQ): how does G at position + 3 result in aberrant splicing?.  Am J Hum Genet. 1999;  65 635-644
• 15 Ohno K, Engel A G, Brengman J M, Shen X M, Heidenreich F, Vincent A. et al . The spectrum of mutations causing end-plate acetylcholinesterase deficiency.  Ann Neurol. 2000;  47 162-170
• 16 Shapira Y A, Sadeh M E, Bergtraum M P, Tsujino A, Ohno K, Shen X M. et al . Three novel COLQ mutations and variation of phenotypic expressivity due to G240 X.  Neurology. 2002;  58 603-609